12 Sep 12
There’s nothing like a tough market to force companies to take stock of their core business and reassess the best use of internal resources. Martin Magazzolo, global practice director of CSC Life Sciences’ Software Solutions Group, charts the move toward content as a service amid changing market dynamics.
12 Sep 12
2013 is tipped to be a milestone year for the global pharmaceutical industry. As a number of key blockbuster drugs face the expiry of their US patents over the next year, a strong opportunity opens up for manufacturers to launch their own generic versions in the US.
Carlo Novi Managing Director Sales, HealthCare Solutions , FedEx Express EMEA
10 Sep 12
The issue of gender balance within UK boards has moved quickly up the business agenda following last year’s Davies Report. Lord Davies’ Women on Boards report outlined the benefits that a mixed board brings in terms of skills and different perspectives and recommended that a minimum of 25% of FTSE 100 board members should be female by 2015.
07 Sep 12
Despite many pledges from Government to change the employment law landscape, this October’s legislative programme is a relatively quiet one for employment lawyers and employers.
28 Aug 12
Becoming an employer of choice is vital to attract and retain staff especially given the current climate of increased competition for talent and employees, according to recruiting experts Hays in China.
Kathy Lou, Marketing Manager of Hays in China
08 Aug 12
Digital marketing in the pharmaceutical & healthcare industry is reaching boiling point. After six or seven years of interest, it’s going mainstream – and instead of “should we go digital?”, pharma & healthcare companies are now asking “how do we do it successfully?”. We think the next seven years, leading up to 2020, will be crucial in this endeavour.
17 Jul 12
What if a diabetes patient’s own cells—taken from his or her own adult tissue—could be made to create insulin, secreting the compound whenever needed? This specific type of cell therapy is a form of what has been called “autologous cell replacement.”
17 Jul 12
Aberdeen scientists have demonstrated for the first time a clear link between sunlight, vitamin D and an impact on regulatory cells in the immune system in findings that might provide new insights into diseases such as multiple sclerosis (MS).
UNIVERSITY OF ABERDEEN
PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.